Featured | Vanrx

Vanrx Pharmasystems introduces the Dynamic Peristaltic Pump

March 18, 2020 - Featured

“The required dosage for many advanced therapies is very low—sometimes 0.5 mL or less. Getting the highest yield from your batch is essential, since each additional dosage treats another patient. Current and future customers will be able to serve their patients better thanks to the new Dynamic Peristaltic Pump,” explains Chris Procyshyn, CEO and co-founder of Vanrx.

Hands off the goods

March 5, 2020 - Article, Featured

Vanrx CEO Chris Procyshyn writes in the latest issue of The Medicine Maker how adopting closed, automated aseptic processing systems is a crucial step to bring 21st century therapies to patients.

Collaboration at work with FUJIFILM Diosynth Biotechnologies

December 17, 2019 - Featured

When looking for a new fill-finish solution for its gene therapy manufacturing operations, CDMO FUJIFILM Diosynth Biotechnologies turned to isolator technology offered by Vanrx Pharmasystems. Thomas Page, Vice President, Engineering and Asset Development, was interviewed by the editor of The Medicine Maker about their experience working with Vanrx.